[Characterization of P. falciparum strains obtained from relapsed patients].
D000243:Adenosine Deaminase / Q000032:analysis*; D000962:Antimalarials / Q000494:pharmacology*; D002738:Chloroquine / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D004588:Electrophoresis, Cellulose Acetate; D005956:Glucose-6-Phosphate Isomerase / Q000032:analysis*; D006801:Humans; D008288:Malaria / Q000469:parasitology*; D008297:Male; D015767:Mefloquine; D008826:Microbial Sensitivity Tests; D009700:Nucleoside Deaminases / Q000032:analysis*; D010963:Plasmodium falciparum / Q000187:drug effects / Q000201:enzymology*; D011804:Quinolines / Q000494:pharmacology; D012008:Recurrence
D000962:Antimalarials; D011804:Quinolines; D002738:Chloroquine; D009700:Nucleoside Deaminases; D000243:Adenosine Deaminase; D005956:Glucose-6-Phosphate Isomerase; D015767:Mefloquine
Caracterização de cepas de P. falciparum coletadas de pacientes recrudescentes.